Cargando…
Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase‐3
Recently we showed that homoarginine supplementation confers kidney protection in diabetic mouse models. In this study we tested whether the protective effect of homoarginine is nitric oxide synthase‐3 (NOS3)‐independent in diabetic nephropathy (DN). Experiments were conducted in NOS3 deficient (NOS...
Autores principales: | Wetzel, Michael D., Stanley, Kristen, Maity, Soumya, Madesh, Muniswamy, Bopassa, Jean C., Awad, Alaa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955794/ https://www.ncbi.nlm.nih.gov/pubmed/33713581 http://dx.doi.org/10.14814/phy2.14766 |
Ejemplares similares
-
Selective inhibition of arginase-2 in endothelial cells but not proximal tubules reduces renal fibrosis
por: Wetzel, Michael D., et al.
Publicado: (2020) -
l‐Homoarginine supplementation prevents diabetic kidney damage
por: Wetzel, Michael D., et al.
Publicado: (2019) -
Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase
por: Yang, Yong-Yu, et al.
Publicado: (2019) -
Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism
por: You, Hanning, et al.
Publicado: (2013) -
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease
por: Jud, Philipp, et al.
Publicado: (2018)